Versant Ventures VI GP, L.P.'s Net Worth
$0
Who is Versant Ventures VI GP, L.P.?
Versant Ventures VI GP, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Monte Rosa Therapeutics, Inc., Oyster Point Pharma, Inc., Pandion Therapeutics Holdco LLC, Passage BIO, Inc., Contineum Therapeutics, Inc., LENZ Therapeutics, Inc., Repare Therapeutics Inc., Century Therapeutics, Inc., Tempest Therapeutics, Inc., and Akero Therapeutics, Inc..
SEC CIK
Versant Ventures VI GP, L.P.'s CIK is 0001777654
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
LENZ Therapeutics, Inc. (GRPH) No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +245.21% | 598.2K |
—
|
—
| 842.16K |
Mar 21
| |||
Form 4
| +594.22% | 14.05M |
$17.00 |
—
| 16.42M |
Jun 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Repare Therapeutics Inc. (RPTX) Snapshot price: $2.8
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -22.54% | -1.45M |
$12.25 | -$9,188,775.00 | 4.98M |
Jun 3 - Jun 6
| |||
Form 4
| -39.68% | -152.07K |
—
|
—
| 231.21K |
Scheduled
|
Aug 5
| ||
Form 4
| -16.37% | -75.00K |
—
|
—
| 383.28K |
Jun 1
| |||
Form 4
| -9.99% | -240.75K |
—
|
—
| 2.17M |
Scheduled
|
May 5
| ||
Form 4
| -10.29% | -350.00K |
—
|
—
| 3.05M |
Scheduled
|
Feb 16
| ||
Form 4
| -9.36% | -600.00K |
—
|
—
| 5.81M |
Scheduled
|
Jan 29
| ||
Form 4
| -7.23% | -500.00K |
—
|
—
| 6.41M |
Scheduled
|
Jan 14
| ||
Form 4
| -10.12% | -325.00K |
—
|
—
| 2.88M |
Scheduled
|
Dec 15
| ||
Form 4
| +64.65% | 6.5M |
$20.00 | $5,000,000.00 | 16.54M |
Jun 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Monte Rosa Therapeutics, Inc. (GLUE) Snapshot price: $5.69
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -14.24% | -1.54M |
$9.41 | -$1,491,041.15 | 9.3M |
Oct 28 - Oct 29
| |||
Form 4
| -8.34% | -567.21K |
$6.00 | -$3,404,791.10 | 6.23M |
Sep 11 - Sep 13
| |||
Form 4
| +3,041.10% | 8.61M |
$19.00 |
—
| 8.9M |
Jun 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Century Therapeutics, Inc. (IPSC) Snapshot price: $1.44
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -7.40% | -914.80K |
$13.03 | -$7,166,610.00 | 11.45M |
Scheduled
|
Aug 9
| ||
Form 4
| -1.43% | -179.00K |
—
|
—
| 12.37M |
Jan 31
| |||
Form 4
| -2.87% | -371.00K |
—
|
—
| 12.55M |
Scheduled
|
Dec 23
| ||
Form 4
| +357.29% | 10.65M |
$20.00 |
—
| 13.63M |
Jun 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Oyster Point Pharma, Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.66M |
—
|
—
|
0
|
Jan 3
| |||
Form 4
| -32.57% | -201.47K |
—
|
—
| 417.07K |
Scheduled
|
Jan 5
| ||
Form 4
| -24.57% | -201.47K |
—
|
—
| 618.55K |
Scheduled
|
Dec 21
| ||
Form 4
| -22.59% | -550.00K |
$14.86 | -$8,160,736.41 | 1.88M |
Scheduled
|
Oct 18
| ||
Form 4
| -19.05% | -322.36K |
—
|
—
| 1.37M |
May 12
| |||
Form 4
| -16.00% | -322.36K |
—
|
—
| 1.69M |
Mar 26
| |||
Form 4
| -12.69% | -325.00K |
—
|
—
| 2.24M |
Scheduled
|
Feb 17
| ||
Form 4
| +1,630.55% | 5.26M |
$16.00 |
—
| 5.58M |
Nov 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |